Table VI.
Mean percentages of PBMCs from breast cancer patients expressing the receptors for cortisol (Gluc-R), prolactin (PRL-R) and growth hormone (GH-R) at T2 and T3.
| T2 | |||||||
|
| |||||||
| Hormone receptors | A Reflexology + SIS |
B Massage + SIS |
C SIS |
A vs. B vs. C f-test p-value |
A vs. B f-test p-value |
A vs. C f-test p-value |
B vs. C f-test p-value |
|
| |||||||
| Gluc-R | 72.6±2.8 | 77.3±2.8 | 68.2±3.1 | 0.09 | 0.70 | 0.89 | 0.09 |
| PRL-R | 70.8±2.8 | 63.7±2.8 | 67.5±3.1 | 0.21 | 0.23 | 1.00 | 1.00 |
| GH-R | 1.8±0.7 | 1.4±0.7 | 1.8±0.8 | 0.91 | 1.00 | 1.00 | 1.00 |
| T3 | |||||||
|
| |||||||
| Gluc-R | 73.9±3.2 | 73.9±3.0 | 74.4±3.2 | 1.00 | 1.00 | 1.00 | 1.00 |
| PRL-R | 74.0±3.1 | 66.5±2.9 | 67.4±3.0 | 0.16 | 0.22 | 0.37 | 1.00 |
| GH-R | 1.1±1.0 | 3.4±0.9 | 1.7±1.0 | 0.23 | 0.30 | 1.00 | 0.71 |
Values are estimated marginal mean ± SEM. Also shown are the results from the univariate analysis of variance. All values are adjusted for baseline.